May 10, 2024 10:47 PM

Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says

Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says Cipla is open to partnering with U.S. drugmaker Eli Lilly to market its blockbuster obesity treatment drugs in India, the company's CEO said on Friday. 'Absolutely and always open...we value our partnership with Lilly tremendously and I think the two companies are culturally aligned," Cipla's Global CEO Umang Vohra said in response to a Reuters query. Global demand has outpaced supply for Lilly's Mounjaro and Ze...